Last updated on July 2018

Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Primary Prevention | VALVULAR HEART DISEASE | Sudden Cardiac Death | Implantable defibrillator
  • Age: Between 19 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients who meet one of the following criteria:
  • Patients who have undergone surgery for aortic valve or mitral valve disease for more than 12 months
  • Patients with severe aortic valve or mitral valve disease
  • Patients with left ventricular ejection fraction 35% by echocardiography or other imaging methods
  • US, European practice guidelines class I indication for ICD implantation
  • Patients without evidence of ischemic heart disease (who meet one of the following criteria):
  • Stress test negative
  • Significant stenosis was not observed in coronary artery images:

epicardial coronary stenosis <70%, left main stenosis <50%

  • History of heart failure symptoms
  • Patients who have received medication for more than 3 months according to the heart failure treatment guideline recommendation

Exclusion Criteria:

  • Patients with left ventricular dysfunction without valvular heart disease
  • Patients who require cardiac pacing therapy due to bradycardia
  • Heart transplant scheduled
  • Life expectancy is less than one year

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.